FDA approves first blood test to help screen for Alzheimer’s disease

The Lumipulse G Plasma Ratio Test offers a new way to detect signs of Alzheimer’s disease by identifying plaque proteins in the blood. Dr. Celine Gounder joins to explain how this could make early diagnosis faster and more accessible.

Submit a Comment

Your email address will not be published. Required fields are marked *

Chat with us.

Hi there! How can I help you? ?